- Home
- BGSF vs DXR Comparison
BGSF vs DXR Comparison
Compare BGSF & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BGSF | DXR |
|---|---|---|
| Founded | 2007 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.8M | 71.4M |
| IPO Year | 2013 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BGSF | DXR |
|---|---|---|
| Price | $5.70 | $9.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 20.3K | 11.8K |
| Earning Date | 05-06-2026 | 02-27-2026 |
| Dividend Yield | ★ 34.84% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $93,310,000.00 | $1,446,345.00 |
| Revenue This Year | $4.67 | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.91 | $7.10 |
| 52 Week High | $8.20 | $14.76 |
Technical Indicators
Market Signals| Indicator | BGSF | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 46.28 | 35.31 |
| Support Level | $5.92 | $8.51 |
| Resistance Level | $6.38 | $9.88 |
| Average True Range (ATR) | 0.30 | 0.40 |
| MACD | -0.06 | 0.05 |
| Stochastic Oscillator | 42.86 | 42.40 |
Price Performance
Historical ComparisonAbout BGSF BGSF Inc.
BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.